UBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.77769998721544E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.57130000122407E-08 |
Normal-vs-Stage2 |
4.619500E-03 |
Normal-vs-Stage3 |
1.71928000000099E-05 |
Normal-vs-Stage4 |
1.72269976062012E-10 |
Stage1-vs-Stage2 |
7.495000E-01 |
Stage1-vs-Stage3 |
2.849800E-01 |
Stage1-vs-Stage4 |
1.323780E-03 |
Stage2-vs-Stage3 |
6.289400E-01 |
Stage2-vs-Stage4 |
4.120400E-02 |
Stage3-vs-Stage4 |
1.134410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.20540000203562E-09 |
Normal-vs-AfricanAmerican |
2.13969999999231E-05 |
Normal-vs-Asian |
4.056400E-03 |
Caucasian-vs-AfricanAmerican |
7.839200E-01 |
Caucasian-vs-Asian |
9.531000E-01 |
AfricanAmerican-vs-Asian |
9.701000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.72804042981079E-12 |
Normal-vs-Female |
6.867600E-02 |
Male-vs-Female |
1.842590E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.39529999963062E-08 |
Normal-vs-Extreme_Weight |
9.60509449754454E-11 |
Normal-vs-Obese |
2.44779999999389E-05 |
Normal-vs-Extreme_Obese |
1.273740E-02 |
Normal_Weight-vs-Extreme_Weight |
9.121800E-01 |
Normal_Weight-vs-Obese |
1.735780E-01 |
Normal_Weight-vs-Extreme_Obese |
9.863400E-01 |
Extreme_Weight-vs-Obese |
8.743900E-02 |
Extreme_Weight-vs-Extreme_Obese |
9.367400E-01 |
Obese-vs-Extreme_Obese |
4.476000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.062200E-03 |
Normal-vs-Age(41-60Yrs) |
2.34200000004403E-06 |
Normal-vs-Age(61-80Yrs) |
6.51189990819034E-10 |
Normal-vs-Age(81-100Yrs) |
7.36789995681164E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.857600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.374400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.362400E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.118010E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.544300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.692050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.14009999721654E-08 |
Normal-VS-Type2 PRCC |
1.66744396068452E-12 |
Normal-VS-KIRP CIMP |
4.839700E-02 |
Normal-VS-Unclassified PRCC |
2.552300E-02 |
Type1 PRCC-VS-Type2 PRCC |
8.49380000000899E-05 |
Type1 PRCC-VS-KIRP CIMP |
3.454200E-01 |
Type1 PRCC-VS-Unclassified PRCC |
6.715200E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.377200E-03 |
Type2 PRCC-VS-Unclassified PRCC |
2.067700E-02 |
KIRP CIMP-VS-Unclassified PRCC |
7.099800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.75648426096132E-12 |
Normal-vs-N1 |
5.78249999999558E-05 |
Normal-vs-N2 |
1.68371E-05 |
N0-vs-N1 |
2.006400E-01 |
N0-vs-N2 |
5.883800E-01 |
N1-vs-N2 |
2.784800E-01 |
|
|